Skip to main content
November 03

November 03, 2015
Bad Homburg, Germany

Quarterly Financial Report Q3 2015 (US-GAAP)

I. V. Drugs

Mediathek Company
Mediathek Topic
Mediathek Date
Mediathek Preview File
525px_web_Fresenius_Kabi_I.V.Drug.jpg
Mediathek Photo Print Version
Image
Mediathek Description Text

A nurse prepares an intravenously administered (I.V.) drug. Fresenius Kabi is a leading supplier of I.V. generic drugs. Seen in the background are Agilia series infusion pumps for the administration of I.V. drugs.

Corporate headquarters

Mediathek Company
Mediathek Topic
Mediathek Date
Mediathek Description Text

Fresenius is a global healthcare company headquartered in Bad Homburg v. d. Höhe, Germany. The Fresenius Group comprises the operating companies Fresenius Kabi and Fresenius Helios as well as an investment in Fresenius Medical Care. With around 140 hospitals and countless outpatient facilities, Fresenius Helios is the leading private hospital operator in Germany and Spain, treating around 26 million patients every year. Fresenius Kabi’s product portfolio touches the lives of 450 million patients annually and includes a range of highly complex biopharmaceuticals, clinical nutrition, medical technology, and intravenous generic drugs and fluids.

Mediathek Preview File
525px_TV_Footage_Konzernzentrale.jpg
Mediathek Download
FSE_TV_Footage_Corporate_Headquarters_1080p_10MBit.mp4
Subscribe to